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Abstract 17 
Evidence suggests that sub-optimal maternal nutrition has implications for the developing 18 
offspring. We have previously shown that exposure to a low-protein diet during gestation was 19 
associated with upregulation of genes associated with cholesterol transport and packaging 20 
within the placenta. This study aimed to elucidate the effect of altering maternal dietary linoleic 21 
acid (LA; omega-6) to alpha-linolenic acid (ALA; omega-6) ratios as well as total fat content 22 
on placental expression of genes associated with cholesterol transport. The potential for 23 
maternal BMI to be associated with expression of these genes in human placental samples was 24 
also evaluated. Placentas were collected from 24 Wistar rats at 20d gestation (term=21-22d 25 
gestation) that had been fed one of four diets containing varying fatty acid compositions during 26 
pregnancy, and from 62 women at the time of delivery. Expression of 14 placental genes 27 
associated with cholesterol packaging and transfer were assessed in rodent and human samples 28 
by qRT-PCR. In rats, placental mRNA expression of ApoA2, ApoC2, Cubn, Fgg, Mttp and Ttr 29 
was significantly elevated (3-30 fold) in animals fed a high LA (36% fat) diet, suggesting 30 
increased cholesterol transport across the placenta in this group. In women, maternal BMI was 31 
associated with fewer inconsistent alterations in gene expression. In summary, sub-optimal 32 
maternal nutrition is associated with alterations in the expression of genes associated with 33 
cholesterol transport in a rat model. This may contribute to altered fetal development and 34 
potentially programme disease risk in later life. Further investigation of human placenta in 35 
response to specific dietary interventions is required. 36 
Key Words: Cholesterol, maternal nutrition, omega, placenta, pregnancy  37 
Draycott et al.                                    High-fat diet and placental CHO transport 
Introduction 38 
Maternal nutrition can have a profound impact on fetal development and future physiological 39 
function and metabolic health (1). A number of dietary perturbations, including maternal 40 
undernutrition and low protein diets, have been associated with increased risk of obesity and 41 
cardiovascular disease in the adult offspring (2, 3). In the context of the growing epidemic of 42 
obesity, focus has shifted towards understanding the effects of nutritional excess and obesity 43 
on offspring programming of disease. Studies have consistently demonstrated that these 44 
exposures are associated with a substantial increase in the risk of poor metabolic health in the 45 
offspring in both humans (4) and animal models (5). There is emerging evidence from animal 46 
studies, however, that maternal high-fat diets also have the potential to program metabolic 47 
outcomes in the offspring independent of the effects of maternal obesity. In addition, these 48 
effects appear to depend not only on the amount of fat in the diet (6), but also on the fatty acid 49 
composition (7, 8). The majority of studies to date that have investigated the effects of a 50 
maternal high fat diet have utilised diets high in saturated fat. However, due to changes in 51 
population level patterns in dietary consumption (9, 10), attention has now shifted toward the 52 
roles of polyunsaturated fats within the diet. 53 
The mechanisms underlying this early life programming of obesity and metabolic disease are 54 
not completely understood. However, as the sole interface between the mother and the fetus, 55 
structural and functional changes within the placenta have been implicated as playing a key 56 
role (11). Cholesterol is present in every cell of the human body and an adequate supply is 57 
therefore critical for supporting normal fetal development. As the precursor for all steroid 58 
hormone synthesis, cholesterol also plays an important role in placental function. During 59 
pregnancy, the fetus obtains cholesterol via endogenous synthesis as well as transfer across 60 
the placenta from the maternal circulation, disturbances to either of these processes have 61 
negative impacts on fetal growth, cell proliferation, metabolism and the organisation of 62 
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tissues (12, 13). The endogenous synthesis of cholesterol appears to be most critical for the 63 
developing fetus, as defects in this pathway are known to be lethal (14). Sub-optimal maternal 64 
contribution of cholesterol across the placenta, however, has been associated with lower 65 
birthweight (15, 16) and microcephaly (16) in humans, highlighting the importance of this 66 
exogenous cholesterol supply.  67 
Transport of cholesterol across the placenta is a complex process in both humans and rodents 68 
(17, 18). Briefly, the majority of cholesterol circulates the body in the form of HDL, LDL and 69 
VLDL cholesterol, which are associated with specific structural apolipoproteins (ApoA2, 70 
ApoB and ApoC2 respectively). The layer of trophoblast cells, located closest to maternal 71 
circulation, take in LDL and VLDL through their respective receptors. HDL cholesterol can 72 
be taken up via a specific receptor (scavenger receptor class B type 1; SR-B1) or by binding 73 
to proteins such as megalin and cubilin (Cubn). Once within the cell, cholesterol is 74 
hydrolysed into free cholesterol, bound to sterol carrier proteins and then transferred to the 75 
basolateral membrane where it passes through the fetoplacental endothelium. The processes 76 
governing cholesterol efflux from the endothelial layer are poorly understood, although it has 77 
been shown that exogenous cholesterol is secreted into fetal circulation, through association 78 
with various transporters (19), where it is repackaged into fetal lipoproteins. This process is 79 
facilitated by microsomal triglyceride transfer protein (Mttp). The finding that the placenta 80 
expresses and secretes its own apolipoproteins such as ApoB (20) also raises the possibility that 81 
cholesterol is repackaged into HDL, LDL and VLDL cholesterol within the placenta itself. 82 
 83 
In addition to its critical role in fetal growth and development, there is emerging evidence 84 
that alterations in placental cholesterol transfer capacity may also be a contributing factor to 85 
metabolic programming. In a previous study(21), we showed providing rats with a low protein 86 
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diet until day 13 of gestation, a dietary treatment previously associated with programming of 87 
obesity, hypertension and glucose intolerance in adult offspring (22, 23), resulted in increased 88 
placental expression of a number of genes associated with cholesterol and lipoprotein 89 
transport and metabolism in the rat.  90 
Given the similarity in the metabolic phenotype induced by maternal obesity/nutritional 91 
excess and low protein diets, we hypothesised that programming of health and disease is 92 
driven by perturbations of a small set of common ‘gatekeeper’ processes (24, 25) and changes in 93 
placental cholesterol transfer and metabolism may be common mechanisms underlying 94 
metabolic programming by different dietary exposures.  Therefore, the aim of this current 95 
study was to investigate the effect of a high maternal dietary omega-6:omega-3 fatty acid 96 
ratio, associated with decreased placental weight (26), against a lower ratio as well as total fat 97 
intake, on the expression of genes associated with cholesterol and lipoprotein transport, 98 
known to be affected by maternal diet, in the mature placenta of the rat. We also aimed to 99 
investigate whether placental expression of these same genes differed according to maternal 100 
body mass index (BMI) in a cohort of pregnant women. 101 
Materials and Methods 102 
Animal Experiments and sample collection  103 
This paper reports data from the analysis of placentas that were collected as part of a previous 104 
study (26). Virgin female Wistar rats (n = 24; 75-100 g; Charles River, UK) were housed on 105 
wood shavings in individually ventilated cages under a 12 h light/12 h dark cycle at a 106 
temperature of 20–22 °C and had ad libitum access to food and water throughout the 107 
experiment. Female rats were allowed to acclimatise to the unit for 1–2 weeks, during which 108 
time they were fed on standard laboratory chow (2018 Teklad Global 18% Protein Rodent 109 
Diet, Harlan Laboratories, UK). After acclimatisation, a tail vein blood sample was taken 110 
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from each animal for the determination of fatty acid status. The rats were then randomly 111 
assigned to one of 4 dietary groups designed to provide either a high (9:1, high LA) or low 112 
(1:1.5 low LA) ratio of linoleic acid (LA) to alpha-linolenic acid (ALA), achieved by altering 113 
the amounts of flaxseed and sunflower oil included in the fat component of the feed. The 114 
levels of saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) were 115 
comparable in all diets, achieved by adjusting the amounts of coconut (SFA source) and 116 
macadamia (MUFA source) oils in the diets. For each level of LA, diets containing either 117 
18% or 36% fat by weight were developed. This resulted in four experimental diets; high LA 118 
(18% fat), high LA (36% fat), low LA (18% fat) and low LA (36% fat) (n =5–7 per dietary 119 
group). The list of ingredients and final fatty acid composition of the four experimental diets 120 
have been published previously (26). 121 
All animal procedures were performed in accordance with the Animals (Scientific 122 
Procedures) Act 1986 under Home Office licence and were approved by the Animal Ethics 123 
Committee of the University of Nottingham, UK. Animals were pair housed from the start of 124 
the experiment until mating, after confirmation of conception animals were individually 125 
housed until completion of the experiment. Animals were maintained on their allocated diet 126 
for a four week ‘feed-in’ period after which they were mated. Conception was confirmed by 127 
the presence of a semen plug and this was recorded as day 0 of pregnancy. Female rats 128 
remained on their respective diets until day 20 of gestation (full term = 22 days) at which 129 
time rat dams were euthanised by CO2 asphyxiation and cervical dislocation and fetuses by 130 
cervical dislocation and exsanguination. All fetuses were weighed and sexed via 131 
measurement of anogenital distance. Placentas from male fetuses were collected for analysis 132 
and a tail sample from the fetus was collected for sex-genotyping by PCR for the SRY gene 133 
(27). Any samples found to be female or inconclusive (n = 5) were not included in placental 134 
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gene expression analysis. Full details of maternal weight gain, food intake and the effect of 135 
the diets on fetal and placental weight are published elsewhere (26). 136 
Human placental sample collection 137 
Ethical approval for the study was obtained from the Derbyshire Research Ethics Committee 138 
(Ref: 09/H0401/90). Placental samples were obtained from patients attending the Department 139 
of Obstetrics and Gynaecology, Royal Derby Hospital, Derby, UK. Patients provided 140 
informed, written consent prior to undergoing elective caesarean section at term gestation 141 
(>37 weeks), indications for which were maternal request, previous elective section or breech 142 
presentation while cases with diabetes, hypertension, pre-eclampsia, were excluded. 143 
Placentae, once checked by the midwife and with the cord clamped, were transported to the 144 
lab within 20 minutes of delivery, where placental villous samples were taken midway 145 
between the cord insertion site and placental periphery and frozen at -80°C prior to extraction 146 
of RNA.  Participants were stratified based on a BMI measurement taken during an antenatal 147 
clinic appointment, resulting in 3 groups of women; BMI <25 kg/m2 (n=20), BMI 25-35 148 
kg/m2 (n=21) and BMI >35 kg/m2 (n=21). 149 
Sample Preparation and PCR 150 
RNA was isolated from 20-25mg of crushed snap-frozen human or rat placental tissue using 151 
the Roche High Pure Tissue kit (Roche Diagnostics Ltd., UK) according to manufacturer’s 152 
instructions. RNA concentration was determined using a Nanodrop 2000 (Thermo Scientific) 153 
and RNA quality was evaluated by agarose gel electrophoresis. cDNA was synthesised using 154 
a RevertAid™ reverse transcriptase kit (Thermo Fisher Scientific, UK) with random hexamer 155 
primers. 156 
Gene targets were chosen based on our previous data (21) where RNASeq analysis of day 13 157 
rat placentas revealed differential expression of 91 genes in response to maternal protein 158 
Draycott et al.                                    High-fat diet and placental CHO transport 
restriction. Ingenuity pathway analysis identified 8 pathways that were significantly affected 159 
(P<0.001), 6 of which were closely related functionally with a strong emphasis of cholesterol 160 
uptake and efflux across the placenta. Genes were selected based upon the ingenuity analysis 161 
(ApoA2, ApoB, ApoC2, Ttr, Fgg, serpin G1 and Rbp4). Additional genes were chosen that 162 
were shown to be differentially expressed in the protein restricted condition (Vil1, Gpc3, 163 
Prf1, Cubn, Mttp) but not associated with pathways identified by Ingenuity analysis. Tagln 164 
and Tbp gene targets were also chosen as preliminary RNASeq analysis suggested that they 165 
may be sensitive to maternal dietary factors, resulting in 14 target genes for analysis. Real-166 
time PCR primers were designed using Primer Express software (version 1.5; Applied 167 
Biosystems) from the RNA sequence, checked using BLAST (National Centre for 168 
Biotechnology Information) and were purchased from Sigma (UK). The primer sequences 169 
can be found in supplementary table S1. Real-time PCR was performed on a Lightcycler 480 170 
(Roche, Burgess Hill, UK) using the 384 well format. Each reaction contained 5μl of cDNA 171 
with the following reagents: 7.5μl SYBR green master mix (Roche), 0.45μl forward and 172 
reverse primers (final concentration 0.3μM each) and 1.6μl RNase-free H2O. Samples were 173 
pre-incubated at 95°C for 5 min followed by 45 PCR amplification cycles (denaturation, 174 
95°C for 10 seconds; annealing, 60°C for 15 seconds; elongation, 72°C for 15 seconds). 175 
Transcript abundance was determined using a standard curve generated from serial dilutions 176 
of a pool of cDNA made from all samples. Expression was normalised against the expression 177 
of cyclophilin A, which was not significantly different between experimental groups. 178 
Statistical Analysis 179 
Data are presented as mean ± SEM. Data were analysed using the Statistical Package for 180 
Social Sciences (Version 24, SPSS Inc.). For animal data the effect of maternal dietary fatty 181 
acid ratio and maternal dietary fat content on placental expression of target genes was 182 
assessed using a two-way ANOVA, with dietary fat level and LA:ALA ratio as factors. 183 
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Human data were analysed using a one-way ANOVA with maternal BMI as a factor. Possible 184 
co-variates were identified and corrected for within the analysis. A value of P<0.05 was 185 
considered statistically significant.  186 
Results 187 
Rat placenta 188 
The results of the gene expression analyses in the rodent placentas is shown in Table 1. 189 
Expression was measured for 13 genes (ApoB excluded), however, Tbp expression was not 190 
detectable in any of the samples (data not shown) and so could not be included in the 191 
analysis.  192 
Placental Mttp mRNA expression was significantly increased (3 fold; P<0.01) in dams 193 
consuming a high LA compared to a low LA diet, independent of total dietary fat content 194 
(Table 1). There was a significant interaction between the effects of maternal total dietary fat 195 
and LA content in relation to mRNA expression of ApoA2, ApoC2, Cubn, Fgg, Rbp4 and Ttr 196 
(P<0.05), such that expression of these genes was significantly increased in rats consuming 197 
the high LA diets, but only when dietary fat content was also high (36% fat w/w). The 198 
magnitude of this effect was greatest for Cubn (30-fold increase in the high LA (36% fat) 199 
group when compared to the low LA (36% fat) group). A similar pattern was observed for 200 
other key cholesterol-transport and metabolism genes in the placenta (Gpc3, P=0.072; Vil1, 201 
P=0.054), with 1.5-7 fold higher expression in placentas of dams exposed to a high LA diet, 202 
but only when dietary fat content was also high. Placental expression of Prf1, SerpinG1 and 203 
Tagln was not affected by either maternal dietary fatty acid ratio or fat content.  204 
Human placenta 205 
The sociodemographic and clinical characteristics of the women who provided placental 206 
samples for this study are summarised in Table 2. The average age, parity and gestation 207 
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length of women within this study was similar between women in the three BMI groups, 208 
however the birth weights of infants born to women with a BMI >25 kg/m2 were significantly 209 
greater than those of women in the normal BMI range. 210 
The results of the gene expression analyses in the human placentas is shown in Table 3. All 211 
14 genes were measured and detected in these samples. Women with a BMI in the 25-35 212 
kg/m2 range (overweight to obese) exhibited a 2-6 fold higher mRNA expression of ApoB in 213 
their placental samples compared to women with a BMI either <25 or >35 kg/m2. The 214 
expression of Rbp4 was significantly lower in placentas obtained from women with a BMI 215 
>25 kg/m2 compared to those with a BMI <25 kg/m2 (85% down-regulation, P=0.001). A 216 
similar pattern was also observed for Ttr, with 71-88% down-regulation of expression in 217 
women with a BMI >25 kg/m2, although this did was not statistically significant (P=0.053). 218 
The mRNA of other placental genes was not different between BMI groups. 219 
Discussion 220 
This experiment aimed to test the hypothesis that maternal diet, specifically, fatty acid 221 
composition and quantity, and obesity would influence the expression of genes associated 222 
with cholesterol uptake and transport in rat and human placenta. The results of the rat studies 223 
suggested clear effects of maternal dietary fat content and composition, such that maternal 224 
consumption of a higher-fat, high LA maternal diet was associated with increased expression 225 
of key genes associated with these pathways, suggesting enhanced cholesterol transport to the 226 
fetus in this group. In the human study, however, only two of these genes were differentially 227 
expressed in placentas from women in different BMI categories, suggesting that maternal 228 
obesity had a limited impact on placental cholesterol transport at the level of gene expression.  229 
Within this study we have shown that exposure to a high LA, high-fat diet resulted in 230 
increased expression of genes involved in the formation of apolipoproteins, cholesterol 231 
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uptake and cholesterol repackaging. These differences were not observed when either the fat 232 
content and/or the fatty acid ratio was altered, suggesting a strong interaction between these 233 
variables. Importantly, the effects observed on the placental gene expression profiles show 234 
striking resemblances to our previous findings (21) where upregulation of these genes was 235 
observed in the placentas of dams exposed to a low protein diet. These data suggest that, not 236 
only do these differences persist to a late stage placenta (day 20), but, despite different 237 
dietary interventions, the similarities in results suggest a common mechanism of action. The 238 
upregulation of key genes in the rat placenta observed in this study suggests a state of 239 
increased cholesterol uptake and efflux. While the potential impacts of this in the current 240 
study are not clear, it has been demonstrated in previous studies that, exposure to excess 241 
cholesterol during fetal development can be associated with adverse outcomes. In rodent 242 
models, maternal hypercholesterolemia has been associated with growth restriction (28), 243 
altered liver development  (29) and atherosclerosis  (30, 31). In humans, maternal 244 
hypercholesterolaemia has been associated with the development of fatty streaks in fetal 245 
arteries and cholestasis during pregnancy is associated with programming of an overweight, 246 
insulin resistant phenotype in the child (32, 33). It will therefore be important in future studies 247 
to determine the longer term consequence of the changes in placental gene expression for the 248 
postnatal offspring.  249 
Based on the substantial impact of maternal high-fat high LA feeding, a dietary pattern 250 
commonly observed in the modern Western diet, we extended our study to determine if there 251 
was any evidence to suggest an effect of maternal obesity on cholesterol transfer in the 252 
human. There were, however, relatively few differences in the expression of key genes 253 
associated with different BMI categories in human placental samples, although there were 254 
some subtle differences in the expression of 3 genes (ApoB, Rbp4 and Ttr) between BMI 255 
categories. Ttr is a protein that binds to and transports Rbp4. In the bound state, Rbp4 is 256 
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protected from glomerular filtration and so levels of these two proteins are often correlated. 257 
As such, the similar patterns of expression across these two genes observed in this study was 258 
anticipated. What was surprising, however, was our finding that women with a BMI above 259 
the normal range (>25 kg/m2, overweight or obese) exhibited decreased placental expression 260 
of these genes since elevated levels of circulating Rbp4 have been associated with many of 261 
the co-morbidities linked to obesity including hypertension (34), insulin resistance and type 2 262 
diabetes (35, 36). It is important to note, however, that these observations have all been 263 
associated with circulating levels of Rbp4, whereas we measured gene expression in the 264 
placenta. There is limited literature evaluating the role of Rbp4 within the placenta during 265 
pregnancy, particularly in association with maternal obesity. It may be, however, that in 266 
obese mothers, placental expression is reduced to compensate for the increased maternal 267 
circulating levels and therefore avoiding fetal exposure to high quantities of Rbp4. Further 268 
experimentation, is required to determine expression of Rbp4 and Ttr in both the mother, 269 
fetus and the placenta throughout pregnancy and their association with maternal obesity.  270 
Placental ApoB expression was increased in women whose BMI was above the normal range 271 
(>25 kg/m2). A study by Dubé and colleagues (37), showed increased circulating ApoB 272 
concentrations in new-born infants of obese mothers, compared to mothers of normal weight, 273 
in the absence of any difference in maternal circulating concentrations. It is therefore possible 274 
that the high ApoB concentrations in infants of obese mothers may have been the result of 275 
increased placental ApoB expression. If this abnormal lipoprotein profile is present in the 276 
offspring and persists through childhood it may contribute to increased risk of cardiovascular 277 
disease in later life. 278 
One key limitation of the current study is that direct measurements of cholesterol transport or 279 
measurement of the genes of interest at the level of protein were not analysed, and so care 280 
must be taken when extrapolating the findings to functional outcomes. Further to this, human 281 
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participants within this study were stratified based on BMI whereas the animal experiments 282 
utilised specific dietary interventions. There are many factors that can affect BMI and, 283 
although nutrition is a key element, there is still a huge variety of nutritional habits that can 284 
lead to individuals resulting in similar BMIs. As such, assumptions cannot be made about 285 
specific nutrient intakes of the women based on this data. Finally, it is important to note that, 286 
whilst there are many similarities between placental physiology and function in the rat and 287 
humans, there are some key differences. Of particular importance to this study is the 288 
difference in circulating progesterone levels at the end of pregnancy. In rodents there is a 289 
dramatic decrease in circulating progesterone (38), whereas in humans, progesterone levels are 290 
increased or at least maintained at the time of parturition (39). Progesterone is a key steroid 291 
produced from cholesterol within the placenta and has been shown to regulate the expression 292 
of some genes including Rbp4 in other tissues (40). As such, careful consideration of the 293 
differences in placental hormone production, particularly steroid hormones, between the two 294 
species should be made when drawing comparisons.  295 
In conclusion, this study aimed to elucidate whether differences in placental expression of 296 
genes involved in cholesterol transport and efflux were associated with altered maternal 297 
nutrition in a manner similar to our previous observations in the low-protein model. We 298 
demonstrated that exposure to high levels of omega-6 as part of a high-fat diet elicited a 299 
similar pattern of placental gene expression, suggesting an increase in cholesterol transport 300 
across the placenta. This highlights the potential for a common mechanism by which sub-301 
optimal maternal nutrition during pregnancy alters placental function, and potentially fetal 302 
development, resulting in increased risk of disease in later life. We then carried out a 303 
preliminary study which aimed to establish if similar alterations were observed in human 304 
placentas. Although BMI was associated with some changes in expression, these observations 305 
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were not consistent and further experimentation is required on placental samples where the 306 
specific nutrient intake of the participants are known.  307 
  308 
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Table 1 Rat placental gene expression at day 20 gestation 452 
* Indicates a significant interaction effect of maternal dietary LA:ALA ratio and total dietary 453 
fat content on placental gene expression (P<0.05). 454 
Different superscript indicate significant differences between groups (P<0.01).  455 
 High LA (18% 
Fat) 
High LA (36% 
Fat) 
Low LA (18% 
Fat) 
Low LA (36% 
Fat) 
ApoA2* 0.75 ± 0.24 3.24 ± 1.13 0.52 ± 0.08 0.33 ± 0.20 
ApoC2* 0.72 ± 0.27 2.91 ± 1.00 0.56 ± 0.08 0.34 ± 0.21 
Cubn* 0.81 ± 0.35 2.92 ± 1.15 0.35 ± 0.06 0.10 ± 0.04 
Fgg* 0.76 ± 0.30 2.97 ± 1.09 0.36 ± 0.06 0.12 ± 0.05 
Gpc3 0.96 ± 0.28 1.46 ± 0.43 0.56 ± 0.09 0.50 ± 0.09 
Mttp 0.66 ± 0.25a 2.12 ± 0.77a 0.28 ± 0.05b 0.22 ± 0.09b 
Prf1 1.65 ± 0.42 0.73 ± 0.14 1.17 ± 0.12 1.15 ± 0.31 
Rbp4* 0.69 ± 0.29 2.34 ± 1.17 0.48 ± 0.12 0.13 ± 0.05 
SerpinG1 1.03 ± 0.26 1.00 ± 0.13 0.84 ± 0.21 1.20 ± 0.33 
Tagln 0.95 ± 0.13 0.87 ± 0.06 0.67 ± 0.04 1.09 ± 0.17 
Ttr* 0.65 ± 0.22 2.43 ± 0.81 0.52 ± 0.08 0.32 ± 0.17 
Vil1 1.23 ± 0.42 2.67 ± 0.97 0.51 ± 0.10 0.54 ± 0.22 
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Table 2 Human participant characteristics 456 
BMI (kg/m2) <25  25-35  >35  
Age (years) 34.29 ± 1.28 33.55 ± 1.07 31.25 ± 1.04 
BMI 21.88 ± 0.36 29.70 ± 0.70 40.10 ± 1.07 
Parity 1.05 ± 0.11 0.75 ± 0.14 1.20 ± 0.19 
Gestation length (weeks) 38.63 ± 0.23 38.68 ± 0.18 38.65 ± 0.20 
Birthweight (g)* 3236 ± 88 3537 ± 112 3565 ± 108 
Sex (% male) 45 45 65 
N 21 20 20 
Data are shown as mean ± SEM for N observations per group. *ANOVA indicated that, with 457 
adjustment for gestational age, birthweight was influenced by maternal BMI (P=0.021)  458 
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Table 3 Human placental gene expression 459 
* Indicates a significant effect of maternal BMI on placental gene expression (**P<0.01). 460 
  461 
 BMI <25 BMI 25-35 BMI >35 
ApoA2 1.04 ± 0.21 1.22 ± 0.27 0.53 ± 0.06 
ApoB** 0.34 ± 0.06 2.19 ± 0.55 1.04 ± 0.25 
ApoC2 0.90 ± 0.15 1.02 ± 0.25 0.76 ± 0.13 
Cubn 1.22 ± 0.21 1.15 ± 0.15 0.86 ± 0.09 
Fgg 0.48 ± 0.14 0.82 ± 0.41 0.65 ± 0.42 
Gpc3 0.97 ± 0.20 1.30 ± 0.20 0.83 ± 0.19 
Mttp 0.57 ± 0.08 1.23 ± 0.37 0.42 ± 0.08 
Prf1 1.14 ± 0.19 0.85 ± 0.10 1.03 ± 0.17 
Rbp4** 0.50 ± 0.13 0.07 ± 0.01 0.08 ± 0.01 
SerpinG1 1.45 ± 0.24 0.90 ± 0.07 0.90 ± 0.11 
Tagln 0.97 ± 0.11 1.04 ± 0.10 1.11 ± 0.10 
Tbp 1.02 ± 0.11 1.16 ± 0.11 1.00 ± 0.07 
Ttr 1.92 ± 0.90 0.23 ± 0.08 0.56 ± 0.20 
Vil1 1.14 ± 0.20 1.82 ± 0.33 1.01 ± 0.18 
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Supplementary Table S1 Primer sequences used for the determination of gene expression by 462 
RT-qPCR 463 
Forward (FWD) and reverse (REV) primer sequences designed using Primer Express 464 
























































































REV:  CGGACTCAGCCCCATCATT 
CTGAGCGCCCAAGTCAAAG 
CATGGCCTCGATCCTCCATA 
